(Total Views: 465)
Posted On: 03/30/2021 11:12:35 AM
Post# of 148899
Re: Riztheinvestor #84753
No, this data was not included in the EUA request. One has to wonder why it took this long to get these results from the data.
From the pr:
“Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, commented, “We will expediently submit an update with the above 14-day benefit to the U.S. FDA, Health Canada, and MHRA and will work closely with regulators in other countries. The Company believes this new information bolsters the case for immediate use of leronlimab for critically ill patients.”
From the pr:
“Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, commented, “We will expediently submit an update with the above 14-day benefit to the U.S. FDA, Health Canada, and MHRA and will work closely with regulators in other countries. The Company believes this new information bolsters the case for immediate use of leronlimab for critically ill patients.”
(2)
(0)Scroll down for more posts ▼
